MinervaX

GlycoVaxyn

This biotechnology company develops bioconjugate vaccines for pharmaceutical partners to prevent and treat bacterial infections.

GIVAX

This biotechnology company develops oral mucosal vaccines to protect children and adults against gastrointestinal diseases like rotavirus and norovirus.

Vaxdyn

Vaxdyn develops multivalent vaccines to prevent antibiotic-resistant bacterial infections for high-risk populations, including hospital patients and those with chronic diseases.

Simplexia

This company develops a vaccine against herpes simplex virus type 2 for patients with genital herpes infections.

Matrubials

This biotechnology company develops milk-derived antibacterial therapeutics to treat infectious diseases like bacterial vaginosis for women.

Affinivax

This biopharmaceutical company develops vaccines against infectious diseases and hospital-associated infections for healthcare providers and public health organisations worldwide.

ArkVax

ArkVax develops low-cost recombinant glycoconjugate vaccines for the livestock industry to protect animals from bacterial diseases and combat antimicrobial resistance.

Astrivax

This biopharmaceutical company develops thermostable vaccines and immunotherapies to prevent or treat infectious diseases and virus-driven cancers for patients worldwide.